SKIN vs SPB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

SKIN

55.7
AI Score
VS
SKIN Wins

SPB

51.8
AI Score

Investment Advisor Scores

SKIN

56score
Recommendation
HOLD

SPB

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SKIN SPB Winner
Revenue 137.02M 2.14B SPB
Net Income -9.30M 23.70M SPB
Gross Margin 68.4% 41.2% SKIN
Net Margin -6.8% 1.1% SPB
Operating Income 1.77M 86.50M SPB
ROE -16.7% 1.3% SPB
ROA -1.9% 0.7% SPB
Total Assets 486.57M 3.58B SPB
Current Ratio 1.76 2.41 SPB
Free Cash Flow -3.53M 133.70M SPB

Relative Price Performance (Last 90 Days)

SKIN 1M: -11.7% · 3M: -1.0% SPB 1M: -0.6% · 3M: +15.1%

Current Technical Phase

SKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.4 · Price: $0.65

SPB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $86.91

Fundamentals Snapshot

Metric SKIN SPB
Market Cap
Forward P/E 4.4 15.5
Trailing P/E 27.5
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.4%
Operating Margin 0.0% 0.2%
EPS -0.24 3.13
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, SKIN is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.